weisssoccermom wrote:Well, you're partially correct but.....
The statistics show that IF a person is going to have a recurrence, then it tends to happen in the first two years. And yes, again IF a recurrence is going to occur, statistics show that 80% of them recur in the first two years. After that, stats show that another 10% occur between year 2-3 with another 5% occurring in year 4 with the remainder being insignificant. That does not, however, correlate with or to survival statistics - they are two entirely different things and must be kept separate.
In addition, a big hurdle with all these statistics is this. Generally, the survival statistics 'clock' starts ticking from the date of the FIRST treatment - be that surgery, radiation or chemotherapy. The recurrence 'clock' starts ticking from the date of the LAST treatment. Again, two different statistics with different parameters.
Researchers at M.D. Anderson Cancer Center at the University of Texas prospectively studied patients with a first solitary liver metastasis who were treated either with hepatic resection or radiofrequency ablation. ….
Present study shows an 80% 3-year survival rate (and a 71% 5-year survival rate) after HR and well-established data showing 10- and 20-year survivors after HR of solitary and multiple metastases, even without adjuvant chemotherapy
Users browsing this forum: No registered users and 6 guests